Apellis' blood disorder drug outdoes Alexion's Soliris in improving hemoglobin levels

Apellis Pharmaceuticals Inc said on Tuesday its experimental drug for a blood disorder showed greater improvement in patients' hemoglobin levels than Alexion Pharmaceuticals Inc's Soliris, in a late-stage study.

Too old? Too slow? No! Debut marathoners may add years to life

First-time marathon runners can add years to their lives and reap the health rewards of lower blood pressure and healthier arteries, even if they take on the challenge in mid- to later life, research showed on Monday.

Health report confirms air contamination in Toronto subway

Air in Toronto’s subway system is polluted, the public health department said in a report issued on Monday calling on the transit system to mitigate it.

Few doctors can legally prescribe opioid-addiction drug

(Reuters Health) - Fewer than one in 10 primary care providers in the U.S. can prescribe the opioid-addiction medication buprenorphine, and access is even more scarce in rural counties hardest hit by overdoses, a new study suggests.

Merck's Keytruda shows mixed results in phase 3 trial for small cell lung cancer

Merck & Co said a phase 3 trial of cancer drug Keytruda in combination with chemotherapy showed an increase in the amount of time patients lived with small cell lung cancer without it getting worse, but did not extend overall survival.

More than a third of U.S. healthcare costs go to bureaucracy

(Reuters Health) - U.S. insurers and providers spent more than $800 billion in 2017 on administration, or nearly $2,500 per person - more than four times the per-capita administrative costs in Canada's single-payer system, a new study finds.

Most older men don't need testosterone replacement, new guidelines say

(Reuters Health) - Older men whose testosterone levels have dropped over the years should only be given testosterone replacement to treat sexual dysfunction, according to new guidelines from the American College of Physicians released on Monday.

Many young women get unnecessary pelvic exams

(Reuters Health) - Although guidelines say most women under age 21 don't need pelvic exams or cervical cancer screenings, a U.S. study suggests many still get these invasive tests.

Drug developers take fresh aim at 'guided-missile' cancer drugs

Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed confidence in an approach that has long fallen short of its promise, an analysis compiled for Reuters shows.

Explainer: Making a new generation of 'guided-missile' cancer drugs work

A class of treatments known as antibody-drug conjugates (ADC) combine cancer-tracking proteins with powerful cell toxins. The therapies are getting a fresh start as dozens of drugmakers test a record number of new compounds in people.

Bloody Philippine drug war fails to curb methamphetamine supply: VP

Philippine President Rodrigo Duterte's war on drugs has only managed to curb the supply of methamphetamines by less than 1% of annual consumption, proof that it has been a bloody failure, his main political rival, the vice president, said on Monday.

Related Videos

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS